Thrombosis and Haemostasis

Article	Citations
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	129
	116
	112
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	105
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	102
	85
Staying on Track: Collagen Fibers Orientation Strongly Affects Thrombi Formation at High Shear	74
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2	71
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	55
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	55
Transient Platelet Hyporesponsiveness in Nonischemic Arrhythmogenic Cardiac Arrest After Achieving Restoration of Spontaneous Circulation in Pigs	53
Predictors, Incidence, and Proximal Extension Rate of Distal Deep Vein Thrombosis in Internal Medicine Wards: Insights from the AURELIO Study	51
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	47
High Anti-ADAMTS13 IgG Levels after Plasma Exchange Predict Delayed ADAMTS13 Normalization in Immune-Mediated Thrombotic Thrombocytopenic Purpura	35
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation	33
Venous Thrombosis Associated with Different Types of SARS-CoV-2 Vaccines in the Netherlands—Results of the TERA Case-Control Study	33
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	32
	31
	28
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	27
Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	25
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	25
Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study	24
Reflections on World Thrombosis Day 2024	24
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	23

The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	23
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	23
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	23
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	22
De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study	21
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	21
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	21
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	20
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	20
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	19
Longitudinal In Vivo Monitoring of Atheroprogression in Hypercholesterolemic Mice Using Photoacoustic Imaging	19
Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	19
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study	19
Perioperative Management of Patients Receiving Factor XI Inhibitors	19
Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model	19
Are More Patients with Thromboembolic Disease Dying Now Than Before?	19
Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists—a Nationwide Linked-data Dutch Study	18
Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders	18
Rivaroxaban Treatment Prevents Atrial Myocyte Hypertrophy in Goats with Persistent Atrial Fibrillation by Inhibition of Protease-Activated Receptor-1	17
Optimal Detection of Atrial Fibrillation in Transient Ischaemic Attack: Rationale and design of the ODEA-TIA trial	17
Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification	16
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials	16
Dual Antiplatelet Therapy or Dual Pathway Inhibition	16
Inherited Thrombophilia as a Risk Factor for Persistent Left Ventricular Thrombus Following Acute Myocardial Infarction	15
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level	15
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis	15
	15
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia	15
Approach to Optimizing Tranexamic Acid Use in Trauma: Potential Utilization of Trauma Phenotypes	15
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production	14
The Prognostic Value of the Age–D-Dimer–Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention	14
Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries	14
Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy–Related Thrombotic Microangiopathy	14
Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding	14
Pulmonary Thromboembolism after Catheter Ablation of Cardiac Arrhythmias	14
Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism	14
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice	13
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases	13
N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity	13
Transfer RNAs are Linked to Ischemic Stroke and Major Bleeding in Patients with End-Stage Kidney Disease	13
	13
Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency	13
Sensitivity to Aortic Rupture in Hereditary Aortic Diseases	13
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear	13
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients	13
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19	12
Thrombosis and Haemostasis 2022 Editors' Choice Papers	12
Cryofibrinogen—Characteristics and Association with Cryoglobulin: A Retrospective Study Out of a Series of 1,712 Samples over 7 Years	12
Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	12
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both?	12

Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	12
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease	12
Platelet-Leukocyte Aggregates: Targeting the Crosstalk	11
	11
Extravascular Binding of Coagulation Factor IX Gives Hemostasis a Boost	11
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer	11
Characterization of Arteriovenous Thrombus Formation and Propagation in a Mouse Arteriovenous Fistula Model	11
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation	11
	11
Risk Factors for Venous Thromboembolism in Women of Childbearing Age	11
Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention	11
Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation	11
	11
Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?	10
Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations	10
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?	10
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia	10
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together	10
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway	10
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis	10
Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII	10
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia	10
Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort	10
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)	9
Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis	9
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype	9
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project	9
Physical and Mechanobiological Basis of Biological Functions of Platelets	9
Assessment of Commutability in Factor VIII Activity Testing Using Fresh Human Plasma Samples	9
Human Platelets Internalize Pregnancy-Specific Glycoprotein-1 (PSG1)	9
Digital Twins for Predictive Modelling of Thrombosis and Stroke Risk: Current Approaches and Future Directions	9
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study)	9
Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin	9
Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters	9
Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study	8
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	8
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study	8
The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction	8
Unveiling the Genetic Landscape of Inherited Primary Hemostasis Disorders by Whole-Exome Sequencing: Insights from a Multicenter Study	8
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	8
	8
F8 genotype and immune tolerance induction outcome in people with hemophilia A and inhibitors: A systematic review and meta-analysis	8
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	8
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	8
Ischemic Stroke Burden Attributable to Household Air Pollution in WHO Regions from 1990 to 2021	8
Association of Anisocytosis with Platelet-rich Thrombi and Stroke Recurrence in Patients Undergoing Thrombectomy	8
Activation of the Acute-Phase Response in Hemophilia	8
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	8
	8
High-Resolution Spatial Profiling Unveils Cellular Heterogeneity in Murine Atherosclerosis	8
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	8
Reply to the Comment: Revisiting Platelet-associated Tissue Factor: Methodological Concerns in Flow Cytometry Detection	8
Blood Levels and Composition of Leukocyte–Platelet Aggregates in Inflammatory Diseases of Various Etiologies	7
Racial Differences in Bleeding Risks among Patients with Atrial Fibrillation: An Ecological Epidemiological Study Comparing Korea and UK Population	7
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	7
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	7
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals	7
	7
Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study	7
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	7
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	7
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	7
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	7
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	7
Navigating Anticoagulation in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac Magnetic Resonance Imaging	7
	7
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	7
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	7
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	7
Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?	7
	7
U-shaped Association of Third-trimester Serum Uric Acid with Postpartum Hemorrhage: Statistical Mediation Effects of Hemoglobin, Fibrinogen, and D-dimer—A Multicenter Cohort Study	7
	7
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	7
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	7
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	7
Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity	6
DOACs for Superficial Vein Thrombosis: Risks of Pooling RCTs and Observational Studies in Comparative Effectiveness	6
Trypsin Activates Human Platelets via Proteolytic Cleavage of Protease-Activated Receptor 4	6
	6

A Happy New Year 2024 from Thrombosis and Haemostasis!	6
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type	6
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease	6
Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Su	6
De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?	6
	6
Factor XIII-A Transglutaminase Contributes to Neutrophil Extracellular Trap (NET)-mediated Fibrin(ogen) Network Formation and Crosslinking	6
Hyperfibrinolysis is Associated with Complement Activation Following Trauma	6
Free Fatty Acids Link Residual Lipid and Thrombotic Risk via Impairment of Aspirin Antiplatelet Effects	6
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study	6
	6
Platelet Aggregation Is Not Altered in Men with Aortic Aneurysms	6
Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases	6
D-β-Hydroxybutyrate Dehydrogenase Mitigates Diabetes-Induced Atherosclerosis through the Activation of Nrf2	5
Practical Machine Learning Model for Early and Accurate Prediction of Disseminated Intravascular Coagulation Before Its Progression to an OVERT Stage	5
Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes	5
Prognostic Value of BARC-defined Bleeding in East Asian Acute Myocardial Infarction Patients: Evidence from Multicentre Registries in Korea and Japan	5
Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia	5
Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy	5
Edoxaban Population Pharmacokinetics in Chinese Patients with Nonvalvular Atrial Fibrillation: Model-Informed Dose Adjustment	5
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis	5
C-reactive Protein, Genetic Susceptibility, and the Long-Term Risk of Venous Thromboembolism in Patients with Past Cancer	5
Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study	5
Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery	5
	5
Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency	5
Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis	5
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk	5
Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction	5
An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary	5
Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid	5
Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices	5
Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis	5
CXCL2 Mediates Lactate Secretion and Promotes Aortic Dissection Formation through the p38/JNK/C-myc Pathways	5
Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII	5
	5
Pleiotrophin Promotes Megakaryocyte Differentiation and Thrombocytopoiesis by Regulating PTPRZ1–Fyn–Akt Signaling in Thrombocytopenia after Allo-HSCT	5
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial	5
Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2	5
Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis	5
Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism	5
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients	5
Stability of Rivaroxaban and Apixaban Anti-Xa Activities in Whole Blood Samples: A French Bicentric Study	4
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin	4
Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	4
	4
Major Bleeding Risk During Concomitant Use of Antiarrhythmic Drugs and Oral Factor Xa Inhibitors: A Nationwide Self-Controlled Case Series Study	4
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review	4
Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage	4
DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study	4
Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation	4
Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction	4
Stroke in Mechanical Circulatory Supported Cardiogenic Shock	4
Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study	4
	4
Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis	4
Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19	4
Left Atrial Spontaneous Echo Contrast: Pathogenesis, Detection, and Modelling	4
Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study	4
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF	4
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects	4
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec	4
Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate	4
Integrating Structured and Unstructured Data for Pulmonary Embolism Identification: Implications for Natural Language Processing (NLP) and Large Language Models (LLMs) in Thrombosis Research	4
Patient Care Pathways and Risk Assessments in Patients with Atrial Fibrillation: A Comparison of Asian versus Non-Asian Cohorts	4
Asn384Ser Mutation in Protein C is Associated with Multiple-Site Thrombosis in a Young Heterozygous Male	4
	4
Comparison of Risk of Serious Cardiovascular Events after Hemorrhagic versus Ischemic Stroke: A Population-Based Study	4
PCSK9 Predicts Adverse Limb Outcomes After Endovascular Revascularization in Diabetic Chronic Limb-threatening Ischemia	4
	4
Binding Promiscuity of Therapeutic Factor VIII	4
P2Y12 Inhibition Suppresses Proinflammatory Platelet–Monocyte Interactions	4
Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials	4
Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A	4
Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations	4
	4
Venous Thromboembolism Outcomes Among Cancer and Non-cancer Patients Managed with Patient-centric Guideline-driven Protocol	4
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study	4
Knockdown of tmem183a in Zebrafish Causes Thrombocytopenia and Reduces Coagulation Factors, Disrupting Hemostasis	4
Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin	4
Quantitative 2D 1H, 13C HSQC NMR Spectroscopy for the Determination of Chondroitin Sulfate and Dermatan Sulfate Content in Danaparoid Sodium	4
Interpretable Clinical–Radiomics Model for Prediction of Blood Stasis and Left Atrial Appendage Thrombus	4
Obesity-Related Traits Mediate the Effects of Educational Attainment on the Risk of Varicose Veins, Venous Thromboembolism, and Phlebitis	4
Direct Oral Anticoagulants versus Standard Therapy in Upper Extremity Deep Vein Thrombosis: Real-World Evidence	4
Elevated Protein S Provides Evidence against Hypoxia-Induced Hypercoagulation in Tibetan Highlanders with PHD2D4E;C127S Polymorphisms	4
Reversible Thrombocytopenia of Functional Platelets after Nose-Horned Viper Envenomation is Induced by a Snaclec	4
Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue	4
An Inhibitory Single-Domain Antibody against Protein Z-Dependent Protease Inhibitor Promotes Thrombin Generation in Severe Hemophilia A and FXI Deficiency	4
Statin Treatment Is Associated with Alterations in the Platelet Lipidome	3
Optimizing Use of High-Sensitivity Troponin for Risk-Stratification of Acute Pulmonary Embolism	3
Safety of Prothrombin Complex Concentrate for Emergency Surgery According to the Oral Factor Xa Inhibitor Level	3
Increased Cancer Risk in Patients with Kidney Disease and Venous Thromboembolism: A Population-Based Cohort Study	3
Strategic Lowering of LDL-Cholesterol Post Ischemic Stroke: Identifying Optimal Targets, Timing, and Therapeutic Approaches	3
Risk Factors and Outcomes of Subsegmental versus More Central Pulmonary Embolism in Patients with Lung Cancer	3
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway	3